A 64-year-old with HFrEF (EF 30%) on ACE inhibitor and beta-blocker remains symptomatic (NYHA II). Which addition has Class I mortality benefit across...

Question

A 64-year-old with HFrEF (EF 30%) on ACE inhibitor and beta-blocker remains symptomatic (NYHA II). Which addition has Class I mortality benefit across EF categories in HFrEF?

Accepted Answer

SGLT2 inhibitor

Answer

Ivabradine

Answer

Hydralazine alone

Answer

Digoxin

Answer

Loop diuretic

us-abim MCQ (SBA): Heart Failure with Reduced EF

A 64-year-old with HFrEF (EF 30%) on ACE inhibitor and beta-blocker remains symptomatic (NYHA II). Which addition has Class I mortality benefit across EF categories in HFrEF?